Lv1
16 积分 2024-03-08 加入
Innovative antibody therapeutic development in China compared with the USA and Europe
5个月前
已完结
Frameworks for transformational breakthroughs in RNA-based medicines
5个月前
已完结
The 60-year evolution of lipid nanoparticles for nucleic acid delivery
5个月前
已完结
Complement in human disease: approved and up-and-coming therapeutics
6个月前
已完结
B Cell–Directed Therapy in Autoimmunity
6个月前
已完结
Sequential immunotherapy: towards cures for autoimmunity
6个月前
已完结
Frontiers in CAR-T cell therapy for autoimmune diseases
6个月前
已完结
Autoimmune diseases and atherosclerotic cardiovascular disease
6个月前
已完结
Systemic lupus erythematosus
6个月前
已完结
Degrader–Antibody Conjugates: Emerging New Modality
6个月前
已完结
皖公网安备34019202002308
